Write in a clean editor, then format for Blood in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Blood is a peer-reviewed journal published by Elsevier, covering Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Blood 12 (2023) 45–58.
Formats any DOI in Blood style. No sign-up. |
| Publishes research in | Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Chronic Myeloid Leukemia Treatments Hematopoietic Stem Cell Transplantation |
| ISSN | 0006-4971 |
| Citation impact (2-yr) | 1.32 |
| h-index | 639 |
| i10-index | 53,989 |
| Total citations | 5,635,348 |
| Article processing charge | $5,000 |
| Top institutions publishing here | The University of Texas MD Anderson Cancer Center |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnostic…
A revision of the nearly 8-year-old World Health Organization classification of the lymphoid neoplasms and the accompanying monograph is being published. It reflects a consensus among hematopathologists, geneticists, and clinicians regarding both updates to current entities as well as the addition of a limited number of new provisional entities. The revision clarifies the diagnosis and…
T HE HISTOLOGIC categorization of lymphoma has been a source of frustration for many years for both clinicians and pathologists.In the last 10 years, much new information has become available about the lymphomas, resulting in recognition of new entities and refinement of previously recognized disease categories, raising the question of whether it is time for…
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults, published in 2010, has found broad acceptance by physicians and investigators caring for patients with AML. Recent advances, for example, in the discovery of the genomic landscape of the disease, in the development of assays…
Mesenchymal stem cells (MSCs) are multipotent cells found in several adult tissues. Transplanted allogeneic MSCs can be detected in recipients at extended time points, indicating a lack of immune recognition and clearance. As well, a role for bone marrow-derived MSCs in reducing the incidence and severity of graft-versus-host disease (GVHD) during allogeneic transplantation has recently…
